Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I–II gastric cancer

Table 2 Relationships between NLR–PLR and clinicopathologic characteristics of 305 patients with stage I–II gastric cancer

Characteristic	NLR–PLR			P
Characteristic	0	1	2	P
Total	120	96	89
Age				0.026
<60 years	77	50	41
≥60 years	43	46	48
Sex				0.735
Male	81	65	56
Female	39	31	33
Tumor location in the stomach				0.029
Upper third	24	28	35
Middle third	29	15	15
Lower third	67	53	39
Tumor size				<0.001
<3 cm	77	48	31
≥3 cm	43	48	58
TNM stage				0.034
IA	31	17	8
IB	25	13	15
IIA	16	18	16
IIB	48	48	50
mGPS				<0.001
0	68	57	33
1	10	11	23
2	2	4	7
PNI				<0.001
0	120	94	68
1	0	2	21
NLR–PLR				<0.001
0	114	70	26
1	6	26	46
2	0	0	17

mGPS modified glasgow prognostic score, PNI prognostic nutritional index, PLT platelet count, NLR neutrophil-to-lymphocyte ratio, PLR platelet-to-lymphocyte ratio